| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Jan, 2026 |
| Sales | 1,750 | 2,820 | 3,140 | 1,560 | 0 |
| Sales Growth | -37.94% | -10.19% | +101.28% | unch | unch |
| Net Income | -14,770 | -18,630 | -12,330 | -14,520 | 0 |
| Net Income Growth | +20.72% | -51.09% | +15.08% | unch | unch |
Anpac Bio-Medical Science ADR (ANPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
AnPac Bio-Medical Science Co., Ltd. is a biotechnology company focused on early cancer screening and detection. AnPac Bio-Medical Science Co., Ltd. is based in China.